Association of Plasma Clusterin Concentration With Severity, Pathology, and Progression in Alzheimer DiseaseMadhav Thambisetty, Simon Lovestone, Petroula Proitsi et al.|Archives of General Psychiatry|2010Cited by 402
The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's diseaseJoel Simrén, Nicholas J. Ashton, Antoine Leuzy et al.|Alzheimer s & Dementia|2021Cited by 354
Inflammatory biomarkers in Alzheimer's disease plasmaAngharad R. Morgan, B. Paul Morgan, Samuel Touchard et al.|Alzheimer s & Dementia|2019Cited by 207
Plasma‐based biomarkers for Aβ and tau predict longitudinal brain atrophy in cognitively healthy elderly and in patients with Alzheimer’s diseaseAntoine Leuzy, Henrik Zetterberg, Nicholas J. Ashton et al.|Alzheimer s & Dementia|2020Cited by 0
Ultrasensitive blood biomarkers to predict cognitive decline and diagnose Alzheimer’s disease in the absence of AT(N) classification as the reference standardJoel Simrén, Nicholas J. Ashton, Antoine Leuzy et al.|Alzheimer s & Dementia|2020Cited by 0